ScholarGate
Βοηθός

Σύγκριση μεθόδων

Εξετάστε τις επιλεγμένες μεθόδους δίπλα-δίπλα· οι γραμμές που διαφέρουν επισημαίνονται.

Κλινική Δοκιμή Φάσης ΙΙΙ Προσαρμοσμένη στον Κίνδυνο×Τυχαιοποιημένη Ελεγχόμενη Δοκιμή (ΤΕΔ)×
ΠεδίοΕπιδημιολογίαΕπιδημιολογία
ΟικογένειαProcess / pipelineProcess / pipeline
Έτος προέλευσης1980s–present1948 (first rigorously conducted RCT — MRC streptomycin trial)
ΔημιουργόςEvolving practice; foundational risk-adjustment principles established by Pocock (1983) and extended by numerous trialistsAustin Bradford Hill; MRC Streptomycin Trial team
ΤύποςConfirmatory randomized trial with baseline risk stratification and covariate adjustmentInterventional experimental study
Θεμελιώδης πηγήPocock, S. J. (1983). Clinical Trials: A Practical Approach. Wiley. ISBN: 978-0471901556Friedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M., & Granger, C. B. (2015). Fundamentals of Clinical Trials (5th ed.). Springer. ISBN: 978-3319185385
Εναλλακτικές ονομασίεςrisk-stratified Phase III trial, covariate-adjusted Phase III RCT, risk-adjusted confirmatory trial, RA-Phase IIIRCT, randomized controlled trial, randomised controlled trial, clinical randomized trial
Συναφείς66
ΣύνοψηA risk-adjusted Phase III clinical trial is a large-scale confirmatory randomized experiment that explicitly incorporates participants' baseline prognostic risk profile into both the randomization process and the primary statistical analysis. By stratifying patients on known risk factors before allocation and adjusting for those factors in the outcome model, the design achieves greater statistical precision, reduces confounding, and produces treatment effect estimates that are more clinically meaningful across patient subgroups.A randomized clinical trial (RCT) is an experimental study design in which participants are randomly assigned to an intervention group or a control group, then followed prospectively to compare outcomes. Random allocation is the defining feature: it distributes known and unknown confounders across groups by chance, making the RCT the strongest individual study design for establishing causal efficacy of a treatment or intervention under controlled conditions.
ScholarGateΣύνολο δεδομένων
  1. v1
  2. 2 Πηγές
  3. PUBLISHED
  1. v1
  2. 2 Πηγές
  3. PUBLISHED

Μετάβαση στην αναζήτηση Λήψη διαφανειών

ScholarGateΣύγκριση μεθόδων: Risk-adjusted Phase III clinical trial · Randomized clinical trial. Ανακτήθηκε στις 2026-06-20 από https://scholargate.app/el/compare